TrialCancer discovery2019

Transcriptomic Profiling of the Tumor Microenvironment Reveals Distinct Subgroups of Clear Cell Renal Cell Cancer: Data from a Randomized Phase III Trial.

A Ari Hakimi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.